Sign In
to Vote &
Create Storyboards.
 
Oxford University has initiated human trials for a new Ebola vaccine just 57 days after development, targeting the Bundibugyo strain amid an outbreak in the Congo and Uganda.
2
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard